Fighting to Preserve the Benefits of the 340B Program
Federal Judge Rules That HHS Has Authority to Approve 340B Rebate Models Last week, the United States District Court for the District of Columbia issued an opinion declaring that HHS has authority…
Trump Executive Order on Most-Favored-Nation Drug Pricing Could Have Impacts on 340B Covered Entities On Monday, President Trump signed an Executive Order asking drug manufacturers to voluntarily lower drug prices to meet…
RWC-340B Reacts to Sen. Cassidy Report on 340B Drug Pricing Program WASHINGTON – Ryan White Clinics for 340B Access (RWC-340B) expresses concerns about the recently released report from Senate HELP…
HHS Will Issue Guidance on 340B Rebate Models within 30 Days In response to prodding by Judge Dabney Friedrich, HHS submitted a filing to the United States District Court for the District…
HRSA Finds Two Drugmakers Overcharged Covered Entities for 340B Drugs HRSA’s fiscal year 2025 manufacturer audit results show that Cycle Pharmaceuticals Ltd. and Rhodes Pharmaceuticals L.P. overcharged covered entities for their 340B…